Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |